Name | 5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]-1,3-thiazolidine-2,4-dione |
---|---|
Synonyms |
5-({6-[(2-Fluorobenzyl)oxy]-2-naphthyl}methyl)-1,3-thiazolidine-2,4-dione
2,4-Thiazolidinedione, 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]- UNII-QOV2JZ647A Isaglitazone 5-({6-[(2-fluorobenzyl)oxy]naphthalen-2-yl}methyl)-1,3-thiazolidine-2,4-dione MCC-555 netoglitazone |
Description | Netoglitazone is a dual agonist of PPARα and PPARγ with antihyperglycemic activity[1]. |
---|---|
Related Catalog | |
Target |
PPARα PPARγ |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 599.5±30.0 °C at 760 mmHg |
Molecular Formula | C21H16FNO3S |
Molecular Weight | 381.420 |
Flash Point | 316.4±24.6 °C |
Exact Mass | 381.083496 |
PSA | 80.70000 |
LogP | 4.50 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.668 |
Storage condition | 2-8°C |
Symbol |
GHS09 |
---|---|
Signal Word | Warning |
Hazard Statements | H410 |
Precautionary Statements | P273-P501 |
Hazard Codes | N |
Risk Phrases | 50/53 |
Safety Phrases | 60-61 |
RIDADR | UN 3077 9 / PGIII |
RTECS | XJ5813445 |
~65% 161600-01-7 |
Literature: Mitsubishi Chemical Corporation Patent: US5594016 A1, 1997 ; |
Precursor 1 | |
---|---|
DownStream 0 |